Central Kentucky Addiction Treatment

Open Now
0.000
Contact Information
128 Daniel Drive, Danville, Kentucky 40422, United States
Detailed Information

Central Kentucky Addiction Treatment

    Services:
    Detoxification (medical withdrawal) Services

    • Opioids detoxification
    • Alcohol Detoxification
    • Methamphetamines detoxification
    • Benzodiazepines Detoxification
    • Medication routinely used during detoxification
    • Cocaine Detoxification

    Education and Counseling Services

    • Hepatitis education, counseling, or support
    • Smoking/vaping/tobacco cessation counseling
    • Substance use disorder education
    • Individual counseling
    • Group counseling

    Transitional Services

    • Outcome follow-up after discharge
    • Aftercare/continuing care

    Facility Operation (e.g., Private, Public)

    • Private for-profit organization

    Type of Alcohol Use Disorder Treatment

    • This facility administers/prescribes medication for alcohol use disorder

    Type of Opioid Treatment

    • Prescribes naltrexone
    • Relapse prevention with naltrexone
    • Buprenorphine detoxification
    • Lofexidine or Clonidine detoxification
    • Prescribes buprenorphine

    Other Services

    • Treatment for gambling disorder
    • Treatment for other addiction disorder

    Gender Accepted

    • Female
    • Male

    Treatment Approaches

    • Substance use disorder counseling
    • Brief intervention
    • Relapse prevention
    • Motivational interviewing
    • Telemedicine/telehealth therapy

    Testing

    • Testing for Hepatitis C (HCV)
    • HIV testing
    • Testing for Hepatitis B (HBV)
    • Drug or alcohol urine screening
    • Breathalyzer or blood alcohol testing

    Age Groups Accepted

    • Adults
    • Children/Adolescents

    Type of Care

    • Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
    • Detoxification
    • Substance use treatment

    Facility Vaping Policy

    • Vaping permitted in designated area

    Assessment/Pre-treatment

    • Comprehensive substance use assessment
    • Screening for substance use
    • Comprehensive mental health assessment
    • Professional interventionist/educational consultant
    • Screening for mental disorders
    • Screening for tobacco use

    Payment/Insurance/Funding Accepted

    • Cash or self-payment

    Recovery Support Services

    • Mentoring/peer support

    Pharmacotherapies

    • Buprenorphine with naloxone
    • Acamprosate (Campral�)
    • Naltrexone (extended-release, injectable)
    • Medications for Hepatitis C treatment
    • Naltrexone (oral)
    • Non-nicotine smoking/tobacco cessation
    • Medication for mental disorders
    • Nicotine replacement
    • Buprenorphine (extended-release, injectable)
    • Clonidine
    • Buprenorphine without naloxone

    Special Programs/Groups Offered

    • Clients with co-occurring pain and substance use disorders
    • Pregnant/postpartum women

    Facility Smoking Policy

    • Smoking permitted in designated area

    Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

    • Outpatient
    • Outpatient methadone/buprenorphine or naltrexone treatment
    • Regular outpatient treatment
    • Outpatient detoxification

    External Source of Medications Used for Alcohol Use Disorder Treatment

    • In-network prescribing entity

    Opioid Medications used in Treatment

    • Buprenorphine used in Treatment
    • Naltrexone used in Treatment
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm